GLP-1-based therapies, such as GLP-1 receptor agonists, glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors, improve glucose control through various mechanisms including increased insulin secretion, slower gastric emptying, and reduced postprandial glucagon and food intake
And 42% of tirzepatide users lost 15% or more of their body weight, compared to just 18% of semaglutide users
What happens if I confuse my Toujeo pen with a GLP-1 pen
A high-fiber diet selectively increases the abundance of beneficial gut bacteria, promotes the production of SCFAs, improves intestinal barrier function, and alleviates metabolic endotoxemia [106]
He added that this could come from neurological changes or changes in salivary production (many GLP-1 users report dry mouths)